Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer

by Giampieri, Riccardo, Scartozzi, Mario, Del Prete, Michela, Faloppi, Luca, Bianconi, Maristella, Ridolfi, Francesca, Cascinu, Stefano
Published in Medicine (Baltimore) (2015)

Optimizing renal function and outcome of patients with cT2 renal cell carcinoma

by Santoni, Matteo, Maiorani, Giada, Faloppi, Luca, Di Nunno, Vincenzo, Gatto, Lidia, Massari, Francesco, Battelli, Nicola
Published in Ann Transl Med (2019)

Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis

by Bittoni, Alessandro, Del Prete, Michela, Scartozzi, Mario, Pistelli, Mirco, Giampieri, Riccardo, Faloppi, Luca, Bianconi, Maristella, Cascinu, Stefano
Published in Springerplus (2015)

Tracking the 2015 Gastrointestinal Cancers Symposium: bridging cancer biology to clinical gastrointestinal oncology

by Aprile, Giuseppe, Leone, Francesco, Giampieri, Riccardo, Casagrande, Mariaelena, Marino, Donatella, Faloppi, Luca, Cascinu, Stefano, Fasola, Gianpiero, Scartozzi, Mario
Published in Onco Targets Ther (2015)

The role of Micro-RNAs in Hepatocellular Carcinoma: From Molecular Biology to Treatment

by D’Anzeo, Marco, Faloppi, Luca, Scartozzi, Mario, Giampieri, Riccardo, Bianconi, Maristella, Del Prete, Michela, Silvestris, Nicola, Cascinu, Stefano
Published in Molecules (2014)

Contemporary best practice in the management of urothelial carcinomas of the renal pelvis and ureter

by Bianconi, Maristella, Cimadamore, Alessia, Faloppi, Luca, Scartozzi, Mario, Santoni, Matteo, Lopez-Beltran, Antonio, Cheng, Liang, Scarpelli, Marina, Montironi, Rodolfo
Published in Ther Adv Urol (2019)

Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach

by Bittoni, Alessandro, Scartozzi, Mario, Giampieri, Riccardo, Faloppi, Luca, Bianconi, Maristella, Mandolesi, Alessandra, Prete, Michela Del, Pistelli, Mirco, Cecchini, Luca, Bearzi, Italo, Cascinu, Stefano
Published 2013

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management

by Scartozzi, Mario, Faloppi, Luca, Bianconi, Maristella, Giampieri, Riccardo, Maccaroni, Elena, Bittoni, Alessandro, Del Prete, Michela, Loretelli, Cristian, Belvederesi, Laura, Svegliati Baroni, Gianluca, Cascinu, Stefano
Published 2012

Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab

by Giampieri, Riccardo, Mandolesi, Alessandra, Abouelkhair, Khaled M, Loretelli, Cristian, Del Prete, Michela, Faloppi, Luca, Maristella, Bianconi, Ibrahim, Ezzeldin M, Scarpelli, Marina, Cascinu, Stefano, Scartozzi, Mario
Published in J Transl Med (2015)

Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report

by Casadei Gardini, Andrea, Chiadini, Elisa, Faloppi, Luca, Marisi, Giorgia, Delmonte, Angelo, Scartozzi, Mario, Loretelli, Cristian, Lucchesi, Alessandro, Oboldi, Devil, Dubini, Alessandra, Frassineti, Giovanni Luca, Ulivi, Paola
Published in BMC Cancer (2016)

Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: Implications for clinical management

by Del Prete, Michela, Giampieri, Riccardo, Loupakis, Fotios, Prochilo, Tiziana, Salvatore, Lisa, Faloppi, Luca, Bianconi, Maristella, Bittoni, Alessandro, Aprile, Giuseppe, Zaniboni, Alberto, Falcone, Alfredo, Scartozzi, Mario, Cascinu, Stefano
Published in Oncotarget (2015)

Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab

by Scartozzi, Mario, Giampieri, Riccardo, Maccaroni, Elena, Mandolesi, Alessandra, Biagetti, Simona, Alfonsi, Simona, Giustini, Lucio, Loretelli, Cristian, Faloppi, Luca, Bittoni, Alessandro, Bianconi, Maristella, Del Prete, Michela, Bearzi, Italo, Cascinu, Stefano
Published 2012

Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients

by Scartozzi, Mario, Loretelli, Cristian, Galizia, Eva, Mandolesi, Alessandra, Pistelli, Mirco, Bittoni, Alessandro, Giampieri, Riccardo, Faloppi, Luca, Bianconi, Maristella, Prete, Michela Del, Bianchi, Francesca, Belvederesi, Laura, Bearzi, Italo, Cascinu, Stefano
Published 2012

Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients

by Giampieri, Riccardo, Scartozzi, Mario, Loretelli, Cristian, Piva, Francesco, Mandolesi, Alessandra, Lezoche, Giovanni, Prete, Michela Del, Bittoni, Alessandro, Faloppi, Luca, Bianconi, Maristella, Cecchini, Luca, Guerrieri, Mario, Bearzi, Italo, Cascinu, Stefano
Published 2013

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

by Faloppi, Luca, Scartozzi, Mario, Bianconi, Maristella, Svegliati Baroni, Gianluca, Toniutto, Pierluigi, Giampieri, Riccardo, Del Prete, Michela, De Minicis, Samuele, Bitetto, Davide, Loretelli, Cristian, D’Anzeo, Marco, Benedetti, Antonio, Cascinu, Stefano
Published 2014

Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma:...

by Scartozzi, Mario, Baroni, Gianluca Svegliati, Faloppi, Luca, Paolo, Marzia Di Pietro, Pierantoni, Chiara, Candelari, Roberto, Berardi, Rossana, Antognoli, Stefania, Mincarelli, Cinzia, Risaliti, Andrea, Marmorale, Cristina, Antico, Ettore, Benedetti, Antonio, Cascinu, Stefano
Published 2010

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib

by Gardini, Andrea Casadei, Scarpi, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Santini, Daniele, de Stefano, Giorgio, Marisi, Giorgia, Negri, Francesca V., Foschi, Francesco Giuseppe, Valgiusti, Martina, Ercolani, Giorgio, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study

by Casadei Gardini, Andrea, Foca, Flavia, Scartozzi, Mario, Silvestris, Nicola, Tamburini, Emiliano, Faloppi, Luca, Brunetti, Oronzo, Rudnas, Britt, Pisconti, Salvatore, Valgiusti, Martina, Marisi, Giorgia, Foschi, Francesco Giuseppe, Ercolani, Giorgio, Tassinari, Davide, Cascinu, Stefano, Frassineti, Giovanni Luca
Published in Sci Rep (2017)

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective...

by Gardini, Andrea Casadei, Scarpi, Emanuela, Marisi, Giorgia, Foschi, Francesco Giuseppe, Donati, Gabriele, Giampalma, Emanuela, Faloppi, Luca, Scartozzi, Mario, Silvestris, Nicola, Bisulli, Marcello, Corbelli, Jody, Gardini, Andrea, Barba, Giuliano La, Veneroni, Luigi, Tamberi, Stefano, Cascinu, Stefano, Frassineti, Giovanni Luca
Published in Oncotarget (2016)

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

by Gardini, Andrea Casadei, Marisi, Giorgia, Faloppi, Luca, Scarpi, Emanuela, Foschi, Francesco Giuseppe, Iavarone, Massimo, Lauletta, Gianfranco, Corbelli, Jody, Valgiusti, Martina, Facchetti, Floriana, Corte, Cristina della, Neri, Luca Maria, Tamberi, Stefano, Cascinu, Stefano, Scartozzi, Mario, Amadori, Dino, Nanni, Oriana, Tenti, Elena, Ulivi, Paola, Frassineti, Giovanni Luca
Published in Oncotarget (2016)